Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma

Clinical Biochemistry

Volumn 45, Issue 13-14, 2012, Pages 1070-1074

  Nafee, Abeer M ^a   Pasha, Heba F ^a   El Aal, Salah M Abd ^a   Mostafa, Naglaa A ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Chronic hepatitis; Clusterin; Hepatocellular carcinoma; Liver cirrhosis

Indexed keywords

ALPHA FETOPROTEIN; CLUSTERIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER INFILTRATION; CANCER INVASION; CHRONIC HEPATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PORTAL VEIN; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

ALPHA-FETOPROTEINS; AREA UNDER CURVE; BLOOD CHEMICAL ANALYSIS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CLUSTERIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PORTAL VEIN; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84866022739     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.04.024     Document Type: Article

References (35)

1. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745-750.
2. El-Zayadi A.R., Abaza H., Shakwy S. Prevalence and epidemiological features of hepatocellular carcinoma in Egypt. A single center experience. Hepatol Res 2001, 19:170-179.
3. El-Zayadi A.R., Bardran H.M., Barxat E.M.F. Hepatocellular carcinoma in Egypt. A single center study over a decade. World J Gastroenterol 2005, 11:5193-5198.
4. Bruix J., Liovet J.M. Hepatocellular carcinoma is surveillance cost effective?. Gut 2001, 48:149-150.
5. Blaschuk O., Burdzy K., Fritz I.B. Purification and characterization of a cell-aggregating factor in ram rete test is fluid. J Biol Chem 1983, 258:7714-7720.
6. Jones S.E., Jomary C. Clusterin. Int J Biochem Cell Biol 2002, 34:427-443.
7. Moosser D.D., Mirimoto R.I. Molecular chaperones and the stress of oncogenesis. Oncogene 2004, 23:2907-2918.
8. Gregersen N., Bolund I., Bross P. Protein misfolding aggregation and degradation in disease. Mol Biotechnol 2005, 31:141-150.
9. Traugakos I.P., Gonos E.S. Clusterin/apoliprotein J in human aging and cancer. Int J Biochem Cell Biol 2002, 34:1430-1448.
10. Rosenberg M.E., Silkensen J. Clusterin: physiologic and pathophysiologic consideration. Int J Biochem Cell Biol 1995, 27:633-645.
11. Poon S., Easterbrook-Smith S.B., Rybchyn M.S. Clusterin is an ATP-independent C heperone with very broad substrate-specificity that stabilizes stressed protein in folding-component state. Biochemistry 2000, 39:15953-15960.
12. French L.E., Wholwend A., Sappino A.D. Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J Clin Invest 1994, 93:877-884.
13. Thomas-Tikhonenko A., Viard leveugle I., Dews M., Wehrili P., Sevignani C., Yu D. Myc-transformed epithelial cell down regulate clusterin which inhibit their growth in vitro and carcinogenesis in vivo. Cancer Res 2004, 64:3126-3136.
14. Zhang L.Y., Ying W.T., Mao Y.S., He H.Z., Liu Y., Wang H.X., et al. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of oesophageal cell carcinoma via proteomic approach. World J Gastroenterol 2003, 9:650-654.
15. Scaltriti M., Brausi M., Amorosi A., Caporali A., Corti Arnaldo C., Bettuzzi S. Clusterin (SGP-2 Apo J) expression is down regulated in low and high grade human prostate. Int J Cancer 2004, 108:23-30.
16. Leskov K.S., Klokov D.Y., Li J., Kinsella T.J., Bothman D.A. Synthesis and functional analysis of nuclear clusterin, a cell death protein. J Biol Chem 2003, 278:1590-1600.
17. July L.V., Beraldi E., So A., Fazli L., Evans K., English J.C., et al. Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo. Mol Cancer Ther 2004, 3:223-232.
18. Miyake H., Hara I., Kamidon S., Gleave M.E. Synergistic chemosensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxy nucleotide targeting clusterin gene in a human bladder cancer model. Clin Cancer Res 2001, 7:4245-4252.
19. Pucci S., Bonanno E., Pichiorri F., Angelonic C., Spagnoli L.G. Modulation of different clusterin isoform in human colon tumorigenesis. Oncogene 2004, 23:2298-2304.
20. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
21. Primary liver cancer in Japan. Clinicopathologic features and result of surgical treatment. Ann Surg 1990, 211:277-287. Liver cancer study group of Japan.
22. Liovet J.M., Bru C., Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999, 329-338.
23. Vauthey J.N., Lauwers G.Y., Esnaola N.F., Do K.A., Belghiti J., Mirza N., et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002, 20:1527-1536.
24. Parkin D.M., Bruy F., Forlay J., Disani P. Global cancer statistics 2002. Cancer J Clin 2005, 55:74-108.
25. Zhang B.H., Yang B.H., Tang Z.Y. Randomized controlled trail of screening of hepatocellular carcinoma. J Cancer Res Clin Oncol 2004, 130:417-422.
26. Collier J., Sherman M. Elevated alpha fetoprotein in benign liver disease. Viral Hepat Rev 1998, 4:31-41.
27. Wong P., Taillefer D., Lakins J., Pinealt J., Chader G., Tenniswood M., et al. Molecular characterization of human TRPM-2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur J Biochem 1994, 221:917-925.
28. Wang Y., Liu Y.H., Mai S.J., He L.J., Liao Y.J., Deng H.X. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. J Gastroenterol Hepatol 2010, 1123-1128.
29. Kang Y.K., Hong S.W., Lee H., Kim W.H. Overexpression of clusterin in human hepatocellular carcinoma. Hum Pathol 2004, 35:1340-1346.
30. Lau Sh., Sham J.S., Xie D., Tzang C.H., Tang D., Ma N., et al. Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 2006, 25:1242-1250.
31. Okano T., Kondo T., Kakisaka T. Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics 2006, 6:3938-3948.
32. Rodriquez-Pineiro A.M., de la Cadena M.P., Lopez-Saco A., Rodriguez-Berrocal F.J. Differential expression of serum clusterin isoforms in colorectal cancer. Mol Cell Proteomics 2006, 5:1647-1657.
33. Stejskal D., Fialla R.R. Evaluation of serum and urine clusterin as a potential marker for urinary bladder cancers. Neoplasma 2006, 53:343-346.
34. Abdul-Rhaman P.S., Lim B.K., Hashimo O.H. Expression of high-abundance protein in sera of patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methods. Electrophoresis 2007, 28:1989-1996.
35. Gofuman E.I., Moshkovski S.A., Tikhonova O.V., Lokhov P.G., Zgoda V.G., Serebryakova M.V., et al. Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions. Biochemistry (Moscow) 2006, 71:354-360.